The Korean Journal of Medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지

Folic acid metabolism and the side effect of the methotrexate in rheumatoid arthritis

류마티스관절염 환자에서 Methotrexate 부작용의 원인과 엽산 대사

Park, Won
박원

  • Published : 20040000
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Chan ES, Cronstein BN. Molecular action of methotrexate in inflammatory diseases. Arthritis Res 4:266-273, 2002. https://doi.org/10.1186/ar419
  2. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111-113, 1995. https://doi.org/10.1038/ng0595-111
  3. Zetterberg H. Methylenetetrahydrofolate reductase and transcobalamin genetic polymorphisms in human spontaneous abortion: biological and clinical implications. Reprod Biol Endocrinol 2:7, 2004.
  4. Bailey LB. Folate, methyl-related nutrients, alcohol, and the MTHFR 677C->T polymorphism affect cancer risk: intake recommendations. Review. J Nutr 133(11 Suppl 1):3748S-3753S, 2003.
  5. Nakai K, Itoh C, Nakai K, Habano W, Gurwitz D. Correlation between C677T MTHFR gene polymorphism, plasma homocysteine levels and the incidence of CAD. Am J Cardiovasc Drugs 1:353-361, 2001. https://doi.org/10.2165/00129784-200101050-00005
  6. Kalayoglu-Besisik S, Caliskan Y, Sargin D, Gurses N, Ozbek U. Methylenetetrahydrofolate reductase C677T polymorphism and toxicity in allogeneic hematopoietic cell transplantation. Transplantation 76:1775-1777, 2003. https://doi.org/10.1097/01.TP.0000093831.63661.DF
  7. Sohn KJ, Croxford R, Yates Z, Lucock M, Kim YI. Effect of the methylenetetrahydrofolate reductase C677T polymorphism on chemosensitivity of colon and breast cancer cells to 5-fluorouracil and methotrexate. J Natl Cancer Inst 96:134-144, 2004. https://doi.org/10.1093/jnci/djh015
  8. 김성규, 전재범, Ahmed El-Sohemy, 박용욱, 이혜순, 엄완식, 김태환, 유대현, 배상철. 류마티스 관절염 환자에서 methotrexate 부작용과 methylenetetrahydrofolate reductase (MTHFR) 유전자 다형성의 상관관계. 대한내과학회지 67:121-130, 2004.
  9. van Ede AE, Laan RF, Rood MJ, Huizinga TW, van de Laar MA, van Denderen CJ,Westgeest TA, Romme TC, de Rooij DJ, Jacobs MJ, de Boo TM, van der Wilt GJ, Severens JL, Hartman M, Krabbe PF, Dijkmans BA, Breedveld FC, van de Putte LB. Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheum 44:1515-1524, 2001. https://doi.org/10.1002/1529-0131(200107)44:7<1515::AID-ART273>3.0.CO;2-7
  10. Toffoli G, Russo A, Innocenti F, Corona G, Tumolo S, Sartor F, Mini E, Boiocchi M. Effect of methylenetetrahydrofolate reductase 677C->T polymorphism on toxicity and homocysteine plasma level after chronic methotrexate treatment of ovarian cancer patients. Int J Cancer 103:294-299, 2003. https://doi.org/10.1002/ijc.10847
  11. Robien K, Schubert MM, Bruemmer B, Lloid ME, Potter JD, Ulrich CM. Predictors of oral mucositis in patients receiving hematopoietic cell transplants for chronic myelogenous leukemia. J Clin Oncol 22:1268-1275, 2004. https://doi.org/10.1200/JCO.2004.05.147
  12. Urano W, Taniguchi A, Yamanaka H, Tanaka E, Nakajima H, Matsuda Y, Akama H, Kitamura Y, Kamatani N. Polymorphisms in the methylenetetrahydrofolate reductase gene were associated with both the efficacy and the toxicity of methotrexate used for the treatment of rheumatoid arthritis, as evidenced by single locus and haplotype analyses. Pharmacogenetics 12:183-190, 2002. https://doi.org/10.1097/00008571-200204000-00002
  13. van Ede AE, Laan RF, Blom HJ, Boers GH, Haagsma CJ, Thomas CM, De Boo TM, van de Putte LB. Homocysteine and folate status in methotrexatetreated patients with rheumatoid arthritis. Rheumatology (Oxford) 41:658-665, 2002. https://doi.org/10.1093/rheumatology/41.6.658
  14. Kishi S, Griener J, Cheng C, Das S, Cook EH, Pei D, Hudson M, Rubnitz J, Sandlund JT, Pui CH, Relling MV. Homocysteine, pharmacogenetics, and neurotoxicity in children with leukemia. J Clin Oncol 21:3084-3091, 2003. https://doi.org/10.1200/JCO.2003.07.056
  15. Kumagai K, Hiyama K, Oyama T, Maeda H, Kohno N. Polymorphisms in the thymidylate synthase and methylenetetrahydrofolate reductase genes and sensitivity to the low-dose methotrexate therapy in patients with rheumatoid arthritis. Int J Mol Med 11:593-600, 2003.